Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1996-6-26
|
pubmed:abstractText |
The functional integrity of striatal post-synaptic dopamine D2 receptors is requested for an effective pharmacologic treatment in patients with extrapyramidal movement disorders. Iodine-123 IBZM Single Photon Emission Computed Tomography (SPECT) is a noninvasive radionuclide technique for the morpho-functional imaging of post-synaptic dopamine D2 receptors. In this study, the results of iodine-123 IBZM SPECT and those of apomorphine tests were compared in 32 patients with extrapyramidal movement disorders--22 patients with idiopathic Parkinson's disease (IPD) and 10 with Parkinson's plus syndrome (PPS). Iodine-123 IBZM uptake was measured as the ratio between striatum and frontal cortex activities. Twenty of 22 IPD patients (91%) responded to apomorphine administration, while in 8 of 10 PPS patients (80%) the apomorphine test was negative. Iodine-123 IBZM uptake was significantly higher (p < 0.01) in IPD patients (1.39 +/- 0.114) than in PPS patients (1.27 +/- 0.078). Similarly, iodine-123 IBZM uptake was significantly higher (p < 0.01) in the patients with positive than in those with negative apomorphine test (1.38 +/- 0.113 vs. 1.26 +/- 0.078). In conclusion, the results of this study demonstrate that iodine-123 IBZM SPECT is a radionuclide technique capable of characterizing the patients with extrapyramidal movement disorders and of selecting the subjects who may respond to pharmacological dopamine treatment.
|
pubmed:language |
ita
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/3-iodo-2-hydroxy-6-methoxy-N-((1-eth...,
http://linkedlifedata.com/resource/pubmed/chemical/Apomorphine,
http://linkedlifedata.com/resource/pubmed/chemical/Benzamides,
http://linkedlifedata.com/resource/pubmed/chemical/Contrast Media,
http://linkedlifedata.com/resource/pubmed/chemical/Dopamine Agonists,
http://linkedlifedata.com/resource/pubmed/chemical/Iodine Radioisotopes,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrrolidines
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0033-8362
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
91
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
207-10
|
pubmed:dateRevised |
2008-10-21
|
pubmed:meshHeading |
pubmed-meshheading:8628932-Adult,
pubmed-meshheading:8628932-Aged,
pubmed-meshheading:8628932-Aged, 80 and over,
pubmed-meshheading:8628932-Apomorphine,
pubmed-meshheading:8628932-Basal Ganglia Diseases,
pubmed-meshheading:8628932-Benzamides,
pubmed-meshheading:8628932-Brain,
pubmed-meshheading:8628932-Contrast Media,
pubmed-meshheading:8628932-Dopamine Agonists,
pubmed-meshheading:8628932-Female,
pubmed-meshheading:8628932-Humans,
pubmed-meshheading:8628932-Iodine Radioisotopes,
pubmed-meshheading:8628932-Male,
pubmed-meshheading:8628932-Middle Aged,
pubmed-meshheading:8628932-Parkinson Disease,
pubmed-meshheading:8628932-Pyrrolidines,
pubmed-meshheading:8628932-Tomography, Emission-Computed, Single-Photon
|
pubmed:year |
1996
|
pubmed:articleTitle |
[Cerebral SPECT with iodine-123 IBZM in patients with extrapyramidal system disorders: the evaluation of its sensitivity in therapy with dopaminergic drugs].
|
pubmed:affiliation |
Röntgen-Diagnostik und Neurologie, Virchow-Klinikum, Medizinische Fakultät, Humboldt-Universität, Berlin, Germany.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract
|